| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Amarin Corporation plc is a pharmaceutical firm dedicated to the research, development, and commercialization of therapeutic solutions for cardiovascular diseases. Its operations span several international regions, including the United States, Germany, Canada, Lebanon, and the United Arab Emirates. The company's flagship product is VASCEPA, an omega-3 fatty acid formulation available by prescription only. This medication acts as an adjunctive therapy to diet, designed to decrease elevated triglyceride levels in adult patients suffering from …
Over the last 12 months, insiders at Amarin Corporation plc have bought $0 and sold $0 worth of Amarin Corporation plc stock.
On average, over the past 5 years, insiders at Amarin Corporation plc have bought $187,390 and sold $26,963 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 160,000 shares for transaction amount of $102,400 was made by Berg Aaron (President and CEO) on 2024‑08‑02.
| 2024-08-02 | Berg Aaron | President and CEO | 160,000 0.0389% | $0.64 | $102,400 | -10.16% | ||
| 2024-01-22 | Holt Patrick | President and CEO | 14,426 0.0033% | $1.09 | $15,724 | -39.30% | ||
| 2023-12-12 | Sale | Ketchum Steven B | Chief Scientific Officer | 34,131 0.0084% | $0.79 | $26,963 | -0.54% | |
| 2023-08-16 | Holt Patrick | President and CEO | 300,000 0.0723% | $1.04 | $312,315 | -18.77% | ||
| 2022-06-13 | WOLD OLSEN PER | 55,000 0.0137% | $1.69 | $92,730 | -21.76% | |||
| 2021-12-15 | Zakrzewski Joseph S | director | 2,000 0.0005% | $3.15 | $6,310 | -52.31% | ||
| 2021-12-14 | Zakrzewski Joseph S | director | 10,000 0.0025% | $3.27 | $32,689 | -52.00% | ||
| 2021-08-12 | Sale | Kalb Michael Wayne | SVP and CFO | 120,000 0.0282% | $5.25 | $630,240 | -41.05% | |
| 2021-06-04 | STACK DAVID M | director | 10,000 0.0026% | $4.54 | $45,350 | -17.42% | ||
| 2021-06-03 | STACK DAVID M | director | 5,000 0.0013% | $4.62 | $23,115 | -19.61% | ||
| 2021-02-01 | Sale | Ketchum Steven B | Chief Scientific Officer | 435,456 0.11% | $8.06 | $3.51M | -39.85% | |
| 2021-01-27 | Sale | Ketchum Steven B | Chief Scientific Officer | 843,258 0.2332% | $8.01 | $6.76M | -33.52% | |
| 2020-11-30 | STACK DAVID M | director | 50,000 0.0125% | $4.86 | $243,035 | +1.61% | ||
| 2020-11-11 | Sale | THERO JOHN F | President and CEO | 827,130 0.2094% | $4.07 | $3.36M | +22.63% | |
| 2020-11-10 | Sale | THERO JOHN F | President and CEO | 307,680 0.0792% | $4.13 | $1.27M | +22.63% | |
| 2020-03-04 | Sale | THERO JOHN F | President and CEO | 400,000 0.1106% | $15.99 | $6.4M | -58.77% | |
| 2020-01-03 | Sale | Zakrzewski Joseph S | director | 600,000 0.0965% | $12.17 | $7.3M | -67.88% | |
| 2019-12-16 | Sale | Berg Aaron | CHIEF COMMERCIAL OFFICER | 86,506 0.02% | $19.03 | $1.65M | -70.15% | |
| 2019-12-16 | Sale | Zakrzewski Joseph S | director | 200,000 0.0424% | $17.42 | $3.48M | -70.15% | |
| 2019-12-16 | Sale | Kalb Michael Wayne | SVP and CFO | 50,000 0.0142% | $23.36 | $1.17M | -70.15% |
| THERO JOHN F | President and CEO | 2739000 13.2429% | $33M | 6 | 9 | +65.82% |
| Berg Aaron | President and CEO | 805380 3.894% | $9.7M | 1 | 4 | <0.0001% |
| Holt Patrick | President and CEO | 314426 1.5202% | $3.79M | 2 | 0 | <0.0001% |
| Zakrzewski Joseph S | director | 196547 0.9503% | $2.37M | 3 | 16 | <0.0001% |
| WOLD OLSEN PER | 149000 0.7204% | $1.8M | 1 | 0 | <0.0001% | |
| STACK DAVID M | director | 40000 0.1934% | $482,000.00 | 3 | 4 | <0.0001% |
| Farrell Michael James | Controller | 6037 0.0292% | $72,745.85 | 1 | 0 | +140.48% |
| Ekman Lars | director | 0 0% | $0 | 1 | 5 | <0.0001% |
| Increased Positions | 37 | +35.24% | 957,015 | +23.44% |
| Decreased Positions | 37 | -35.24% | 441,129 | -10.8% |
| New Positions | 10 | New | 83,485 | New |
| Sold Out Positions | 19 | Sold Out | 137,407 | Sold Out |
| Total Postitions | 105 | 0% | 5M | +12.63% |
| Sarissa Capital Management Lp | $17,047.00 | 0.3% | 1.24M | 0 | 0% | 2025-09-30 |
| Kynam Capital Management, Lp | $7,904.00 | 0.14% | 576,111 | 0 | 0% | 2025-09-30 |
| Acadian Asset Management Llc | $6,264.00 | 0.11% | 456,580 | +215,532 | +89.42% | 2025-09-30 |
| Morgan Stanley | $3,700.00 | 0.07% | 269,663 | +106,697 | +65.47% | 2025-09-30 |
| Eversept Partners, Lp | $2,295.00 | 0.04% | 167,276 | 0 | 0% | 2025-09-30 |
| Millennium Management Llc | $1,816.00 | 0.03% | 132,391 | +87,147 | +192.62% | 2025-09-30 |
| Citadel Advisors Llc | $1,678.00 | 0.03% | 122,291 | +76,835 | +169.03% | 2025-09-30 |
| Scp Investment, Lp | $1,372.00 | 0.02% | 100,000 | -25,000 | -20% | 2025-09-30 |
| Bnp Paribas Financial Markets | $1,199.00 | 0.02% | 87,366 | +11,425 | +15.04% | 2025-09-30 |
| Susquehanna International Group, Llp | $1,099.00 | 0.02% | 80,109 | +37,327 | +87.25% | 2025-09-30 |